An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...

A federal judge on Thursday declined to block the bankruptcy sale of genetic testing company 23andMe to its co-founder Anne ...

CT is your last chance to file a claim with 23andMe for a 2023 data breach that may have compromised your genetic data.

One group of people may receive up to $1,500, and much sooner than they think. There is a catch: only some may qualify for ...

OraSure’s board is said to have rejected the proposal without entering discussions. This is Zwanziger’s second attempt to ...

EPHA4 pathway dysfunction causes axon pathfinding defects, resulting in impaired coordinated left-right locomotion by disrupting neural patterning and the function of central pattern generators, ...